TrialDiabetologia2018

Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial.

Jelena P Seferovic et al.PubMed ↗Publisher ↗

No numbers read from the abstract.